Analysen zu Novo Nordisk
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Neutral | UBS AG | |
| 05.08.25 | Novo Nordisk Neutral | UBS AG | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 30.07.25 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 18.07.25 | Novo Nordisk Buy | UBS AG | |
| 18.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.07.25 | Novo Nordisk Buy | UBS AG | |
| 15.07.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.07.25 | Novo Nordisk Buy | UBS AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG | |
| 17.06.25 | Novo Nordisk Buy | UBS AG | |
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.06.25 | Novo Nordisk Buy | UBS AG | |
| 12.06.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 09.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | UBS AG | |
| 06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.06.25 | Novo Nordisk Buy | UBS AG | |
| 02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | Novo Nordisk Halten | DZ BANK | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research |
Aktuelle Aktienanalysen
| 31.03.26 | Ferrari Outperform | RBC Capital Markets | |
| 31.03.26 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 31.03.26 | adidas Buy | Jefferies & Company Inc. | |
| 31.03.26 | Ferrari Buy | Jefferies & Company Inc. | |
| 31.03.26 | SUSS MicroTec Verkaufen | DZ BANK | |
| 31.03.26 | Daimler Truck Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | AUMOVIO Hold | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Outperform | Bernstein Research | |
| 31.03.26 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 31.03.26 | Hermès Outperform | RBC Capital Markets | |
| 31.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 31.03.26 | ams buy | Baader Bank | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Beiersdorf Hold | Jefferies & Company Inc. | |
| 31.03.26 | Philips Market-Perform | Bernstein Research | |
| 31.03.26 | Eni Buy | UBS AG | |
| 31.03.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 31.03.26 | CTS Eventim Buy | Deutsche Bank AG | |
| 31.03.26 | Porsche Automobil Halten | DZ BANK | |
| 31.03.26 | Unilever Underperform | RBC Capital Markets | |
| 31.03.26 | SUSS MicroTec Buy | Warburg Research | |
| 31.03.26 | JOST Werke Buy | Warburg Research | |
| 31.03.26 | Akzo Nobel Hold | Deutsche Bank AG | |
| 31.03.26 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 31.03.26 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Sixt Buy | Deutsche Bank AG | |
| 31.03.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 31.03.26 | Medios Buy | Deutsche Bank AG | |
| 31.03.26 | CANCOM Buy | Deutsche Bank AG | |
| 31.03.26 | K+S Sell | Deutsche Bank AG | |
| 31.03.26 | SUSS MicroTec Buy | Deutsche Bank AG | |
| 31.03.26 | Inditex Buy | Deutsche Bank AG | |
| 31.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 31.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 31.03.26 | Saint-Gobain Neutral | Goldman Sachs Group Inc. | |
| 31.03.26 | Heidelberg Materials Buy | Goldman Sachs Group Inc. | |
| 31.03.26 | FRIEDRICH VORWERK Underperform | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Deutsche Börse Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Volvo AB Buy | UBS AG | |
| 31.03.26 | Daimler Truck Neutral | UBS AG | |
| 31.03.26 | TRATON Buy | UBS AG | |
| 31.03.26 | Daimler Truck Underperform | Bernstein Research | |
| 31.03.26 | Volvo AB Market-Perform | Bernstein Research | |
| 31.03.26 | TRATON Market-Perform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.